News
DGX
189.81
+1.29%
2.42
Weekly Report: what happened at DGX last week (0504-0508)?
Weekly Report · 16h ago
Is It Time To Reassess Quest Diagnostics (DGX) After Recent Share Price Weakness?
Simply Wall St · 2d ago
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
Seeking Alpha · 3d ago
Bullish Quarterly Results: 3 Companies Raising Guidance
NASDAQ · 4d ago
Quest Diagnostics: Updating Levels After Q1 Earnings
Seeking Alpha · 4d ago
Weekly Report: what happened at DGX last week (0427-0501)?
Weekly Report · 05/04 10:01
Quest Diagnostics Prices $500 Million Senior Notes Offering
TipRanks · 05/01 21:43
Is Quest’s New 2036 Notes Offering and Upbeat 2026 Outlook Altering The Investment Case For Quest Diagnostics (DGX)?
Simply Wall St · 05/01 16:56
2 Things Matter Most in Picking Winning Stocks, Says This Market Pro
Barron‘s · 04/30 04:30
2 Things Matter Most in Picking Winning Stocks, -2-
Barron‘s · 04/30 04:30
2026 Market Cap Madness Championship: Loren v. Emily
The Motley Fool · 04/29 23:26
5 Must-Read Analyst Questions From Quest’s Q1 Earnings Call
Barchart · 04/28 03:18
Quest Diagnostics prices $500M of senior notes
Seeking Alpha · 04/27 20:22
Quest Diagnostics Prices $500 Million of Senior Notes
PR Newswire · 04/27 20:10
Weekly Report: what happened at DGX last week (0420-0424)?
Weekly Report · 04/27 10:02
Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely
Seeking Alpha · 04/24 14:53
These Companies Are Raising Guidance This Earnings Season
NASDAQ · 04/23 22:23
Is Quest Diagnostics (DGX) Price Justified After Strong Multi‑Year Share Performance?
Simply Wall St · 04/23 20:09
Quest Diagnostics added as new short idea at Hedgeye
Seeking Alpha · 04/23 15:52
More
Webull provides a variety of real-time DGX stock news. You can receive the latest news about Quest Diagnostics Inc through multiple platforms. This information may help you make smarter investment decisions.
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.